RedHill Biopharma Ltd. (RDHL) Reports Results for the Second Quarter of 2013
7/23/2013 9:28:04 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TEL-AVIV, Israel, July 22, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary formulations and combinations of existing drugs, today reported financial results for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.